Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStretch marks during or after Wegovy treatment are a common concern, and the honest answer is nuanced. Rapid weight loss can make existing stretch marks more visible as the skin adjusts, while significant weight gain prior to treatment is a common cause of the marks themselves. Neither outcome is guaranteed, and your skin's response depends on factors well outside any medicine's control. Like all prescription weight-loss treatments, Wegovy (semaglutide) is a prescription-only medicine available only following a clinical assessment by a qualified prescriber, who can discuss your individual circumstances fully.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Stretch marks (medically called striae) form when the middle layer of skin stretches faster than it can remodel. The collagen and elastin fibres that keep skin supple tear under the pressure, leaving the characteristic streaked marks that fade from red or purple to silver over time. Weight gain, pregnancy, rapid growth in adolescence and prolonged use of corticosteroids are the best-documented triggers.
This matters when people ask about Wegovy specifically, because many people starting semaglutide already carry stretch marks from the weight gain that preceded treatment. Those marks do not disappear with weight loss. In fact, as the tissue beneath the skin contracts, existing marks can look more defined for a period, not because the medicine caused them, but because the skin is redraping over a smaller frame.
A question our prescribers hear most weeks is whether Wegovy will make stretch marks worse. The candid clinical answer is that the medicine itself is not identified as a direct cause of new striae in the published trial data. What drives the skin changes most people notice is the speed and scale of weight loss, combined with the skin's individual capacity to contract.
For a deeper look at how semaglutide works at a physiological level, the mechanism behind Wegovy is worth reading before your consultation.
The STEP 1 trial, published in the New England Journal of Medicine, showed average weight reductions of around 15% over 68 weeks in adults taking semaglutide 2.4 mg alongside lifestyle changes. That scale of loss (often 15–25 kg or more) is meaningful enough to affect how skin sits and behaves.
Skin elasticity declines naturally with age, sun exposure, smoking and genetics. Collagen production slows from the mid-twenties onwards. Someone losing a substantial amount of weight at 50 will typically see more loose skin than someone in their thirties losing the same proportion, for exactly this reason. Stretch marks already present may look lighter and flatter as skin contracts gradually, or they may appear more visible while the body adjusts. If you are curious about how demand for this treatment has grown, the broader semaglutide market offers useful context on how widely it is now used across the UK and beyond.
There is no medicine, cream or procedure that reverses fully established stretch marks. Topical treatments with some supporting evidence (retinoids, hyaluronic acid serums) appear to work best on newer red or purple marks, and any results are modest. This is worth being realistic about before starting treatment, so expectations are grounded in what skin biology can actually deliver.
Maintaining adequate protein intake during treatment matters here. Semaglutide significantly reduces appetite, and people eating far less than usual can fall short of the protein their body needs for tissue repair and skin turnover. Discussing nutritional priorities with your prescriber is a practical step, not a footnote.
There is no clinical protocol for stretch mark prevention during GLP-1 treatment, because the evidence base for topical interventions is limited. What does have solid grounding is looking after the building blocks skin needs to adapt. Staying well hydrated supports skin suppleness; the NHS healthy weight guidance emphasises diet quality alongside any medical weight-loss approach for exactly this reason.
Resistance or strength training during treatment is one of the most useful things you can do for body composition, skin tightening and muscle preservation simultaneously. Progressive loading gives the skin time to contract alongside gradual changes in the underlying tissue, rather than facing a sudden reduction with no structural support. People who want to understand how this treatment reached so many patients so quickly may find it interesting to read about when Wegovy first became available, which also helps explain why clinical experience with skin-related outcomes is still accumulating.
If you are concerned about loose skin or want guidance tailored to your treatment plan, exploring the broader weight-loss treatment options available through a clinician-led service is a sensible starting point. A prescriber who knows your full picture (current weight, rate of loss, nutritional status) can give you specific advice that no article can match.
People thinking about the cost side of long-term treatment sometimes find it useful to review how Wegovy is priced in the UK before committing, so there are no surprises as treatment progresses.
Most skin changes during semaglutide treatment are cosmetic and self-limiting. However, a few presentations are worth flagging to your prescriber promptly. Any sudden rash, widespread skin reaction or signs of an allergic response should be reported immediately. Severe dehydration from GI side effects (persistent vomiting or diarrhoea) affects skin quality acutely and can also affect kidney function; the NHS semaglutide page outlines which side effects warrant medical attention and which are expected to settle. For those interested in the commercial backdrop to availability and pricing, how Wegovy compares in terms of market share sheds light on why supply and access have shifted considerably in recent years.
Slower GI absorption during semaglutide treatment can also affect how certain oral medicines are absorbed, including some supplements taken for skin health. If you are taking collagen supplements, biotin or other oral skin-focused products, mention them at your clinical review, not because they are harmful, but because timing matters. It is also worth knowing that the way Wegovy has been marketed has shaped many patients' initial expectations, so reviewing that context can help you separate evidence-based claims from promotional messaging before your consultation.
If your concerns go beyond what you have read here, our clinical team is accessible seven days a week through aftercare. You can review how the service works on the about us page. For a consultation with our prescribers, starting with a free consultation is the right first step, they can factor skin concerns into your overall treatment plan from the outset.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.